Retatrutide Will Send a Shockwave Through the GLP-1 World
Phase 2 data show roughly 24% mean weight loss at 48 weeks with retatrutide. With Phase 3 and an outcomes trial underway, here is how a triple agonist could reset the GLP-1 era.
D, DOct 20, 20258 min read
Read More